Cambridge Nutritional Sciences plc
(the 'Company' or 'CNS')
Director/PDMR Shareholding
CNS (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that it has received notification that Carolyn Rand, Non-Executive Chair of the Company, has purchased 150,000 ordinary shares of 4 pence each in the Company ("Ordinary Shares"), at an average price of 2.32 pence each. Jeremy Millard, Non-Executive Director of the Company, has also purchased 168,776 Ordinary Shares in the Company, at a price of 2.37 pence each.
A summary of Carolyn Rand and Jeremy Millard's resultant holdings is below:
|
Director |
Board Position |
Number of Ordinary Shares acquired |
Total beneficial holding of Ordinary Shares following this acquisition |
|
|
Number of Ordinary Shares |
Approximate % of Company's issued share capital |
|||
|
Carolyn Rand |
Non-Executive Chair |
150,000 |
347,500 |
0.14% |
|
Jeremy Millard |
Non-Executive Director |
168,776 |
1,193,776 |
0.50% |
Contacts:
|
Cambridge Nutritional Sciences plc |
||||
|
Carolyn Rand, Non-Executive Chair |
||||
|
James Cooper, Interim Chief Executive |
||||
|
Cavendish Capital Markets Limited |
Tel: 020 7220 0500 |
|||
|
Geoff Nash / Edward Whiley (Corporate Finance) |
||||
|
Nigel Birks / Harriet Ward (ECM) |
||||
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.
Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||
|
a) |
Name |
Carolyn Rand |
||||||
|
2 |
Reason for the notification |
|||||||
|
a) |
Position/status |
Non-Executive Chair |
||||||
|
b) |
Initial notification /Amendment |
Initial Notification |
||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
|
a) |
Name |
Cambridge Nutritional Sciences plc |
||||||
|
b) |
LEI |
2138007U9P4BTZTYIR92 |
||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 4 pence each ISIN: GB00B1VCP282 |
||||||
|
b) |
Nature of the transaction |
Ordinary Shares purchased |
||||||
|
c) |
Price(s) and volume(s) |
|
||||||
|
d) |
Aggregated information -Aggregated volume - Price |
Aggregated volume - 150,000 Price - 2.3216 |
||||||
|
e) |
Date of the transaction |
18.11.2025 |
||||||
|
f) |
Place of the transaction |
London Stock Exchange |
||||||
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Jeremy Millard |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
Non-Executive Director |
||||
|
b) |
Initial notification /Amendment |
Initial Notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Cambridge Nutritional Sciences plc |
||||
|
b) |
LEI |
2138007U9P4BTZTYIR92 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 4 pence each ISIN: GB00B1VCP282 |
||||
|
b) |
Nature of the transaction |
Ordinary Shares purchased |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information -Aggregated volume - Price |
As above. |
||||
|
e) |
Date of the transaction |
18.11.2025 |
||||
|
f) |
Place of the transaction |
London Stock Exchange |
||||